Accuitis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $1M

  • Investors
  • 6

Accuitis General Information

Description

Operator of a clinical-stage pharmaceutical company focused on the development of new drugs to address under-served disease states. The company specializes in developing and marketing drug therapies for the treatment of rosacea and other topical skin and eye diseases, providing patients with drugs for the treatment of rosacea.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1005 Alderman Drive
  • Suite 104
  • Alpharetta, GA 30005
  • United States
+1 (678)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1005 Alderman Drive
  • Suite 104
  • Alpharetta, GA 30005
  • United States
+1 (678)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuitis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A2) 31-Aug-2018 $1M Completed Clinical Trials - General
2. Later Stage VC (Series A1) 05-Sep-2017 Completed Startup
1. Grant Completed Startup
To view Accuitis’s complete valuation and funding history, request access »

Accuitis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Accuitis’s complete cap table history, request access »

Accuitis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accuitis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlanta Technology Angels Angel Group Minority
Iron Bridge Capital Partners Growth/Expansion Minority
Bio/Med Investor Network Angel Group Minority
Georgia Research Alliance Not-For-Profit Venture Capital Minority
GRA Venture Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Accuitis FAQs

  • When was Accuitis founded?

    Accuitis was founded in 2011.

  • Where is Accuitis headquartered?

    Accuitis is headquartered in Alpharetta, GA.

  • What is the size of Accuitis?

    Accuitis has 3 total employees.

  • What industry is Accuitis in?

    Accuitis’s primary industry is Drug Discovery.

  • Is Accuitis a private or public company?

    Accuitis is a Private company.

  • What is the current valuation of Accuitis?

    The current valuation of Accuitis is .

  • What is Accuitis’s current revenue?

    The current revenue for Accuitis is .

  • How much funding has Accuitis raised over time?

    Accuitis has raised $2.75M.

  • Who are Accuitis’s investors?

    Atlanta Technology Angels, Iron Bridge Capital Partners, Bio/Med Investor Network, Georgia Research Alliance, and GRA Venture Fund are 5 of 6 investors who have invested in Accuitis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »